Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.76 EUR | +1.61% | -0.43% | -17.87% |
05/06 | SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion | CI |
28/05 | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
Evolution of the average Target Price on SCHOTT Pharma AG & Co. KGaA
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering SCHOTT Pharma AG & Co. KGaA
BERENBERG | Victoria Lambert |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
UBS | Olivier Calvet |
JEFFERIES | James Vane-Tempest |
BARCLAYS | Gaurav Jain |
EPS Revisions
- Stock Market
- Equities
- 1SXP Stock
- 1SXP Stock
- Consensus SCHOTT Pharma AG & Co. KGaA